Literature DB >> 1503497

The interleukin-2 receptor in lesions and serum of bullous pemphigoid.

D Zillikens1, A Ambach, M Schuessler, R Dummer, A A Hartmann, G Burg.   

Abstract

The interleukin-2 receptor (IL-2R) is mainly expressed on activated T cells. Depending on its rate of synthesis, a portion is released from the cell surface as soluble IL-2R (sIL-2R). Since the role of mononuclear cells in the pathology of bullous pemphigoid (BP) is not well understood, we determined the sIL-2R in both blister fluid and serum of 15 BP patients with generalized disease before initiating systemic treatment. In addition, we obtained both lesional and perilesional skin biopsies and examined the mononuclear infiltrate with a panel of monoclonal antibodies. In BP blisters, sIL-2R levels were significantly increased (2070 +/- 350 U/ml), (+/- SEM) compared with serum samples taken at the time of blister puncture (1340 +/- 290 U/ml). In six patients with blisters due to second-degree burns or friction and in five suction blister volunteers, sIL-2R levels were normal in both blisters and serum. In BP, elevated serum levels decreased to normal during therapy, correlating with disease activity. The immunohistology showed that 30% of mononuclear cells in the dermal infiltrate of lesional skin expressed the IL-2R, whereas only 15% were positive in perilesional skin. IL-2R-positive cells are the most likely source of the shed receptor in BP blisters. Our results indicate the presence of activated T cells in lesions and peripheral blood of BP and thus underline the importance of cell-mediated immune mechanisms in the pathology of this disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1503497     DOI: 10.1007/bf00372706

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  30 in total

1.  [Immune phenotyping of mononuclear infiltrate in bullous pemphigoid].

Authors:  A Ambach; D Zillikens; B Klingert; A A Hartmann; G Burg
Journal:  Hautarzt       Date:  1992-02       Impact factor: 0.751

2.  Soluble interleukin-2 receptors in patients with systemic sclerosis. Clinical and laboratory correlations.

Authors:  D Degiannis; J R Seibold; M Czarnecki; J Raskova; K Raska
Journal:  Arthritis Rheum       Date:  1990-03

3.  Interleukin-2 receptor expression in human mast cells and basophils.

Authors:  N Maggiano; F Colotta; F Castellino; R Ricci; S Valitutti; L M Larocca; P Musiani
Journal:  Int Arch Allergy Appl Immunol       Date:  1990

Review 4.  The multi-subunit interleukin-2 receptor.

Authors:  T A Waldmann
Journal:  Annu Rev Biochem       Date:  1989       Impact factor: 23.643

Review 5.  Bullous pemphigoid.

Authors:  N Korman
Journal:  J Am Acad Dermatol       Date:  1987-05       Impact factor: 11.527

6.  Bullous pemphigoid, an ultrastructural study of the inflammatory response: eosinophil, basophil and mast cell granule changes in multiple biopsies from one patient.

Authors:  A M Dvorak; M C Mihm; J E Osage; T H Kwan; K F Austen; B U Wintroub
Journal:  J Invest Dermatol       Date:  1982-02       Impact factor: 8.551

7.  Morphologic and functional evidence for release of mast-cell products in bullous pemphigoid.

Authors:  B U Wintroub; M C Mihm; E J Goetzl; N A Soter; K F Austen
Journal:  N Engl J Med       Date:  1978-02-23       Impact factor: 91.245

8.  Interleukin-2 receptor expression and interleukin-2 production in bullous pemphigoid.

Authors:  J Schaller; T Giese; M Ladusch; U F Haustein
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

9.  Serum-soluble interleukin 2 receptor in psoriasis. Failure to reflect clinical improvement.

Authors:  D Kemmett; J A Symons; G B Colver; G W Duff
Journal:  Acta Derm Venereol       Date:  1990       Impact factor: 4.437

10.  Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro.

Authors:  L A Rubin; C C Kurman; M E Fritz; W E Biddison; B Boutin; R Yarchoan; D L Nelson
Journal:  J Immunol       Date:  1985-11       Impact factor: 5.422

View more
  6 in total

1.  Detection of elevated levels of IL-4, IL-6, and IL-10 in blister fluid of bullous pemphigoid.

Authors:  E Schmidt; B Bastian; R Dummer; H P Tony; E B Bröcker; D Zillikens
Journal:  Arch Dermatol Res       Date:  1996-06       Impact factor: 3.017

2.  Elevated levels of soluble tumour necrosis factor receptor I in blister fluids of bullous pemphigoid and suction blisters.

Authors:  A Zentner; J Rendl; I Grelle; R Dummer; E B Bröcker; D Zillikens
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

3.  Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid.

Authors:  R Chen; G Ning; M L Zhao; M G Fleming; L A Diaz; Z Werb; Z Liu
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

4.  Interleukin-16 expression and release in bullous pemphigoid.

Authors:  A Frezzolini; G Cianchini; M Ruffelli; S Cadoni; P Puddu; O De Pità
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

5.  A novel ELISA reveals high frequencies of BP180-specific IgE production in bullous pemphigoid.

Authors:  Kelly A N Messingham; Megan H Noe; Marisa A Chapman; George J Giudice; Janet A Fairley
Journal:  J Immunol Methods       Date:  2009-05-05       Impact factor: 2.303

Review 6.  Experimental models for the autoimmune and inflammatory blistering disease, Bullous pemphigoid.

Authors:  Lisa Leighty; Ning Li; Luis A Diaz; Zhi Liu
Journal:  Arch Dermatol Res       Date:  2007-09-19       Impact factor: 3.017

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.